Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Multicenter, Single Blind, Randomized, Comparative and add-on Clinical Trial, in Three Parallel Groups, to Evaluate Efficacy and Safety of a New Therapy With Adipose-derived Autologous Stem Cells for the Treatment of Complex Perianal Fistulas in Patients Without Inflammatory Bowel Disease

NCT00475410 is registered in ClinicalTrials.gov with Tigenix S.A.U. as lead sponsor.

NCT NCT00475410
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00475410 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Multicenter, Single Blind, Randomized, Comparative and add-on Clinical Trial, in Three Parallel Groups, to Evaluate Efficacy and Safety of a New Therapy With Adipose-derived Autologous Stem Cells for the Treatment of Complex Perianal Fistulas in Patients Without Inflammatory Bowel Disease
Lead sponsor
Tigenix S.A.U.
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2007
Completion date
August 31, 2009
Enrollment
214 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

anal fistula